BridgeMD
New treatment option for Home Based Rehabilitation
Official title Effect of Untact Upper Extremity Rehabilitation Using a Smart Board for Late Subacute and Chronic Patients With Brain Disorder
ClinicalTrials.gov ID: NCT06837363
What this study is testing
- What it's testing
- The aim is to clinically validate the clinical efficacy, usability, and safety of home-based upper limb rehabilitation training using the Neofect Smart Board by comparing the effects between a group using the home-based Neofect Smart Board and a group performing conventional home-based occupational therapy in patients with upper limb dysfunction in the late subacute and chronic stages of neurological diseases.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 85
You may be able to join if
- Patients with neurological diseases aged 19 to 85 years old
- Patients with hemiparesis lasting for more than 3 months due to neurological diseases (stroke, traumatic brain injury, brain tumor) and impaired...
- Patients with shoulder flexor and adductor muscle strength of MRC grade 2 or higher
- Patients with shoulder extensor and abductor spasticity of MAS grade 1+ or lower
- Participants with sufficient cognitive function to understand the instructions from the researcher and the smart board, and to perform the tasks...
You likely can't join if
- pre-existing significant neurogenic disorders
- major psychiatric disorders such as schizophrenia, bipolar disorder, or dementia
- History of diseases that caused pain or muscle atrophy in the affected upper limb before the onset of the neurological disease, which interfered with...
- Severe spasticity of the affected upper limb (Modified Ashworth Scale score ≥3)
- skin disorders or open wounds on the affected upper limb
- Amputation, fractures, or soft tissue-related diseases or injuries on the affected upper limb
See the full eligibility criteria
- Patients with neurological diseases aged 19 to 85 years old
- Patients with hemiparesis lasting for more than 3 months due to neurological diseases (stroke, traumatic brain injury, brain tumor) and impaired upper limb function
- Patients with shoulder flexor and adductor muscle strength of MRC grade 2 or higher
- Patients with shoulder extensor and abductor spasticity of MAS grade 1+ or lower
- Participants with sufficient cognitive function to understand the instructions from the researcher and the smart board, and to perform the tasks (K-MMSE ≥21)
- pre-existing significant neurogenic disorders
- major psychiatric disorders such as schizophrenia, bipolar disorder, or dementia
- History of diseases that caused pain or muscle atrophy in the affected upper limb before the onset of the neurological disease, which interfered with rehabilitation
- Severe spasticity of the affected upper limb (Modified Ashworth Scale score ≥3)
- skin disorders or open wounds on the affected upper limb
- Amputation, fractures, or soft tissue-related diseases or injuries on the affected upper limb
- severe pain that interferes with rehabilitation of the affected upper limb (Numeric Rating Scale \> 6)
- Inability to maintain a seated posture for more than 10 minutes, which is required for using the smart board
- Significant visual impairment to the extent that the screen cannot be recognized when using the smart board
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.